the weighted average remaining life for amortizable intangible assets at march 31 , 2016 was 18.4 years . we also recorded goodwill of $ 76.5 million based on the amount by which the purchase price exceeded the fair value of the net assets acquired . goodwill is not deductible for income tax purposes . the pro forma effect of this acquisition on revenues and earnings was not material . however , revenues recorded during the period ended march 31 , 2016 were $ 10.7 million since the date of the acquisition . acquisition of insight pharmaceuticals on september 3 , 2014 , the company completed the acquisition of insight , a marketer and distributor of feminine care and other otc healthcare products , for $ 745.9 million in cash after receiving a return of approximately $ 7.2 million from escrow related to an arbitrator 's ruling . the closing followed the ftc approval of the acquisition and was finalized pursuant to the terms of the purchase agreement announced on april 25 , 2014. pursuant to the insight purchase agreement , the company acquired 27 otc brands sold in north america ( including related trademarks , contracts and inventory ) , which extended the company 's portfolio of otc brands to include a leading feminine care platform in the united states and canada anchored by monistat , the leading north american brand in otc yeast infection treatment . the acquisition also added brands to the company 's cough & cold , pain relief , ear care and dermatological platforms . in connection with the ftc 's approval of the insight acquisition , we sold one of the competing brands that we acquired from insight on the same day as the insight closing . insight is primarily included in our north american otc healthcare segment . the insight acquisition was accounted for in accordance with the business combinations topic of the fasb asc 805 , which requires that the total cost of an acquisition be allocated to the tangible and intangible assets acquired and liabilities assumed based upon their respective fair values at the date of acquisition . we prepared an analysis of the fair values of the assets acquired and liabilities assumed as of the date of acquisition . during the quarter ended june 30 , 2015 , we adjusted the fair values of the assets acquired and liabilities assumed by increasing goodwill for certain immaterial items that came to our attention subsequent to the date of acquisition . additionally , during the quarter ended december 31 , 2015 , we reduced goodwill , as we received $ 7.2 million as a result of a finalized arbitration ruling relating to a disputed working capital calculation as determined under gaap , as of the date of the insight acquisition , which is clearly and directly related to the purchase price . the following table summarizes our allocation of the assets acquired and liabilities assumed as of the september 3 , 2014 acquisition date , after giving effect of the adjustments noted above . 38 replace_table_token_9_th based on this analysis , we allocated $ 599.6 million to indefinite-lived intangible assets and $ 124.8 million to amortizable intangible assets . we are amortizing the purchased amortizable intangible assets on a straight-line basis over an estimated weighted average useful life of 16.2 years . the weighted average remaining life for amortizable intangible assets at march 31 , 2016 was 14.6 years . we also recorded goodwill of $ 96.3 million based on the amount by which the purchase price exceeded the fair value of the net assets acquired after of the adjustments described above . goodwill is not deductible for income tax purposes . the operating results of insight have been included in our consolidated financial statements beginning september 3 , 2014. on september 3 , 2014 , we sold one of the brands we acquired from the insight acquisition for $ 18.5 million , for which we had allocated $ 17.7 million , $ 0.6 million and $ 0.2 million to intangible assets , inventory and property , plant and equipment , respectively . the following table provides our unaudited pro forma revenues , net income and net income per basic and diluted common share had the results of insight 's operations been included in our operations commencing on april 1 , 2013 , based upon available information related to insight 's operations . this pro forma information is not necessarily indicative either of the combined results of operations that actually would have been realized by us had the insight acquisition been consummated at the beginning of the period for which the pro forma information is presented , or of future results . replace_table_token_10_th acquisition of the hydralyte brand on april 30 , 2014 , we completed the acquisition of the hydralyte brand in australia and new zealand from the hydration pharmaceuticals trust of victoria , australia , which was funded through a combination of cash on hand and our existing senior secured credit facility . 39 hydralyte is the leading otc brand in oral rehydration in australia and is marketed and sold through our care pharma subsidiary . hydralyte is available in pharmacies in multiple forms and is indicated for oral rehydration following diarrhea , vomiting , fever , heat and other ailments . hydralyte is included in our international otc healthcare segment . the hydralyte acquisition was accounted for in accordance with the business combinations topic of the fasb asc 805 , which requires that the total cost of an acquisition be allocated to the tangible and intangible assets acquired and liabilities assumed based upon their respective fair values at the date of acquisition . we prepared an analysis of the fair values of the assets acquired and liabilities assumed as of the date of acquisition . the following table summarizes our allocation of the assets acquired and liabilities assumed as of the april 30 , 2014 acquisition date . story_separator_special_tag brands that can be continually enhanced by new product offerings generally warrant a higher valuation and longer life than a brand that has always “ followed the leader ” . after consideration of the factors described above , as well as current economic conditions and changing consumer behavior , management prepares a determination of an intangible asset 's value and useful life based on its analysis . under accounting guidelines , goodwill is not amortized , but must be tested for impairment annually , or more frequently if an event occurs or circumstances change that would more likely than not reduce the fair value of the reporting unit below the carrying amount . in a similar manner , indefinite-lived assets are not amortized . they are also subject to an annual impairment test , or more frequently if events or changes in circumstances indicate that the asset may be impaired . additionally , at each reporting period an evaluation must be made to determine whether events and circumstances continue to support an indefinite useful life . intangible assets with finite lives are amortized over their respective estimated useful lives and must also be tested for impairment whenever events or changes in circumstances indicate that the carrying value of the asset may not be recoverable and exceeds its fair value . on an annual basis , during the fourth fiscal quarter , or more frequently if conditions indicate that the carrying value of the asset may not be recovered , management performs a review of both the values and , if applicable , useful lives assigned to goodwill and intangible assets and tests for impairment . we report goodwill and indefinite-lived intangible assets in three reportable segments : north american otc healthcare , international otc healthcare and household cleaning . we identify our reporting units in accordance with the fasb asc subtopic 280. the carrying value and fair value for intangible assets and goodwill for a reporting unit are calculated based on key assumptions and valuation methodologies previously discussed . as a result , any material changes to these assumptions could require us to record additional impairment in the future . in the past , we have experienced declines in revenues and profitability of certain brands in the north american otc healthcare and household cleaning segments . sustained or significant future declines in revenue , profitability , other adverse changes in expected operating results , and or unfavorable changes in other economic factors used to estimate fair values of certain brands could indicate that fair value no longer exceeds carrying value , in which case a non-cash impairment charge may be recorded in future periods . 45 goodwill as of february 29 , our annual impairment review date , and march 31 , 2016 , we had 15 reporting units with goodwill . as part of our annual test for impairment of goodwill , management estimates the discounted cash flows of each reporting unit to estimate their respective fair values . in performing this analysis , management considers current information and future events , such as competition , technological advances and reductions in advertising support for our trademarks and trade names , that could cause subsequent evaluations to utilize different assumptions . in the event that the carrying amount of the reporting unit exceeds the fair value , management would then be required to allocate the estimated fair value of the assets and liabilities of the reporting unit as if the unit was acquired in a business combination , thereby revaluing the carrying amount of goodwill . indefinite-lived intangible assets at each reporting period , management analyzes current events and circumstances to determine whether the indefinite life classification for a trademark or trade name continues to be valid . if circumstances warrant a change to a finite life , the carrying value of the intangible asset would then be amortized prospectively over the estimated remaining useful life . management tests the indefinite-lived intangible assets for impairment by comparing the carrying value of the intangible asset to its estimated fair value . since quoted market prices are seldom available for trademarks and trade names such as ours , we utilize present value techniques to estimate fair value . accordingly , management 's projections are utilized to assimilate all of the facts , circumstances and expectations related to the trademark or trade name and estimate the cash flows over its useful life . in a manner similar to goodwill , future events , such as competition , technological advances and reductions in advertising support for our trademarks and trade names , could cause subsequent evaluations to utilize different assumptions . once that analysis is completed , a discount rate is applied to the cash flows to estimate fair value . in connection with this analysis , management : reviews period-to-period sales and profitability by brand ; analyzes industry trends and projects brand growth rates ; prepares annual sales forecasts ; evaluates advertising effectiveness ; analyzes gross margins ; reviews contractual benefits or limitations ; monitors competitors ' advertising spend and product innovation ; prepares projections to measure brand viability over the estimated useful life of the intangible asset ; and considers the regulatory environment , as well as industry litigation . finite-lived intangible assets when events or changes in circumstances indicate the carrying value of the assets may not be recoverable , management performs a review similar to indefinite-lived intangible assets to ascertain the impact of events and circumstances on the estimated useful lives and carrying values of our trademarks and trade names . if the analysis warrants a change in the estimated useful life of the intangible asset , management will reduce the estimated useful life and amortize the carrying value prospectively over the shorter remaining useful life . management 's projections are utilized to assimilate all of the facts , circumstances and expectations related to the trademark or trade name and estimate the cash flows over its useful life . future

loss on the extinguishment of debt . on september 3 , 2014 , the borrower entered into term loan amendment no . 2. term loan amendment no . 2 provides for ( i ) the creation of a new class of term b-2 loans under the 2012 term loan in an aggregate principal amount of $ 720.0 million , ( ii ) increased flexibility under the credit agreement governing the 2012 term loan and 2012 abl revolver , including additional investment , restricted payment and debt incurrence flexibility and financial maintenance covenant relief , and ( iii ) an interest rate on ( x ) the term b-1 loans that was based , at the borrower 's option , on a libor rate plus a margin of 3.125 % per annum , with a libor floor of 1.00 % , or an alternate base rate , with a floor of 2.00 % , plus a margin , and ( y ) the term b-2 loans that was based , at the borrower 's option , on a libor rate plus a margin of 3.50 % per annum , with a libor floor of 1.00 % , or an alternate base rate , with a floor of 2.00 % , plus a margin ( with a margin step-down to 3.25 % per annum , based upon achievement of a specified secured net leverage ratio ) . also , on september 3 , 2014 , the borrower entered into abl amendment no . 3. abl amendment no . 3 provides for ( i ) a $ 40.0 million increase in revolving commitments under the 2012 abl revolver and ( ii ) increased flexibility under the credit agreement governing the 2012 term loan and 2012 abl revolver , including additional investment , restricted payment and debt incurrence flexibility . borrowings under the 2012 abl revolver , as amended , bear interest at a rate per annum equal to an applicable margin , plus , at the borrower 's option , either ( i ) a base rate determined by reference to the highest of ( a ) the federal funds rate plus 0.50 % , ( b ) the prime rate of citibank , n.a.


 Write a concise suspicious activity report of the following text delimited by triple backquotes. Return your response as a formal report which covers the key points highlighting the location,dates,entity names and account holder information in chronological order of the text.
     ```loss on the extinguishment of debt . on september 3 , 2014 , the borrower entered into term loan amendment no . 2. term loan amendment no . 2 provides for ( i ) the creation of a new class of term b-2 loans under the 2012 term loan in an aggregate principal amount of $ 720.0 million , ( ii ) increased flexibility under the credit agreement governing the 2012 term loan and 2012 abl revolver , including additional investment , restricted payment and debt incurrence flexibility and financial maintenance covenant relief , and ( iii ) an interest rate on ( x ) the term b-1 loans that was based , at the borrower 's option , on a libor rate plus a margin of 3.125 % per annum , with a libor floor of 1.00 % , or an alternate base rate , with a floor of 2.00 % , plus a margin , and ( y ) the term b-2 loans that was based , at the borrower 's option , on a libor rate plus a margin of 3.50 % per annum , with a libor floor of 1.00 % , or an alternate base rate , with a floor of 2.00 % , plus a margin ( with a margin step-down to 3.25 % per annum , based upon achievement of a specified secured net leverage ratio ) . also , on september 3 , 2014 , the borrower entered into abl amendment no . 3. abl amendment no . 3 provides for ( i ) a $ 40.0 million increase in revolving commitments under the 2012 abl revolver and ( ii ) increased flexibility under the credit agreement governing the 2012 term loan and 2012 abl revolver , including additional investment , restricted payment and debt incurrence flexibility . borrowings under the 2012 abl revolver , as amended , bear interest at a rate per annum equal to an applicable margin , plus , at the borrower 's option , either ( i ) a base rate determined by reference to the highest of ( a ) the federal funds rate plus 0.50 % , ( b ) the prime rate of citibank , n.a.
```    
 Suspicious Activity Report : the weighted average remaining life for amortizable intangible assets at march 31 , 2016 was 18.4 years . we also recorded goodwill of $ 76.5 million based on the amount by which the purchase price exceeded the fair value of the net assets acquired . goodwill is not deductible for income tax purposes . the pro forma effect of this acquisition on revenues and earnings was not material . however , revenues recorded during the period ended march 31 , 2016 were $ 10.7 million since the date of the acquisition . acquisition of insight pharmaceuticals on september 3 , 2014 , the company completed the acquisition of insight , a marketer and distributor of feminine care and other otc healthcare products , for $ 745.9 million in cash after receiving a return of approximately $ 7.2 million from escrow related to an arbitrator 's ruling . the closing followed the ftc approval of the acquisition and was finalized pursuant to the terms of the purchase agreement announced on april 25 , 2014. pursuant to the insight purchase agreement , the company acquired 27 otc brands sold in north america ( including related trademarks , contracts and inventory ) , which extended the company 's portfolio of otc brands to include a leading feminine care platform in the united states and canada anchored by monistat , the leading north american brand in otc yeast infection treatment . the acquisition also added brands to the company 's cough & cold , pain relief , ear care and dermatological platforms . in connection with the ftc 's approval of the insight acquisition , we sold one of the competing brands that we acquired from insight on the same day as the insight closing . insight is primarily included in our north american otc healthcare segment . the insight acquisition was accounted for in accordance with the business combinations topic of the fasb asc 805 , which requires that the total cost of an acquisition be allocated to the tangible and intangible assets acquired and liabilities assumed based upon their respective fair values at the date of acquisition . we prepared an analysis of the fair values of the assets acquired and liabilities assumed as of the date of acquisition . during the quarter ended june 30 , 2015 , we adjusted the fair values of the assets acquired and liabilities assumed by increasing goodwill for certain immaterial items that came to our attention subsequent to the date of acquisition . additionally , during the quarter ended december 31 , 2015 , we reduced goodwill , as we received $ 7.2 million as a result of a finalized arbitration ruling relating to a disputed working capital calculation as determined under gaap , as of the date of the insight acquisition , which is clearly and directly related to the purchase price . the following table summarizes our allocation of the assets acquired and liabilities assumed as of the september 3 , 2014 acquisition date , after giving effect of the adjustments noted above . 38 replace_table_token_9_th based on this analysis , we allocated $ 599.6 million to indefinite-lived intangible assets and $ 124.8 million to amortizable intangible assets . we are amortizing the purchased amortizable intangible assets on a straight-line basis over an estimated weighted average useful life of 16.2 years . the weighted average remaining life for amortizable intangible assets at march 31 , 2016 was 14.6 years . we also recorded goodwill of $ 96.3 million based on the amount by which the purchase price exceeded the fair value of the net assets acquired after of the adjustments described above . goodwill is not deductible for income tax purposes . the operating results of insight have been included in our consolidated financial statements beginning september 3 , 2014. on september 3 , 2014 , we sold one of the brands we acquired from the insight acquisition for $ 18.5 million , for which we had allocated $ 17.7 million , $ 0.6 million and $ 0.2 million to intangible assets , inventory and property , plant and equipment , respectively . the following table provides our unaudited pro forma revenues , net income and net income per basic and diluted common share had the results of insight 's operations been included in our operations commencing on april 1 , 2013 , based upon available information related to insight 's operations . this pro forma information is not necessarily indicative either of the combined results of operations that actually would have been realized by us had the insight acquisition been consummated at the beginning of the period for which the pro forma information is presented , or of future results . replace_table_token_10_th acquisition of the hydralyte brand on april 30 , 2014 , we completed the acquisition of the hydralyte brand in australia and new zealand from the hydration pharmaceuticals trust of victoria , australia , which was funded through a combination of cash on hand and our existing senior secured credit facility . 39 hydralyte is the leading otc brand in oral rehydration in australia and is marketed and sold through our care pharma subsidiary . hydralyte is available in pharmacies in multiple forms and is indicated for oral rehydration following diarrhea , vomiting , fever , heat and other ailments . hydralyte is included in our international otc healthcare segment . the hydralyte acquisition was accounted for in accordance with the business combinations topic of the fasb asc 805 , which requires that the total cost of an acquisition be allocated to the tangible and intangible assets acquired and liabilities assumed based upon their respective fair values at the date of acquisition . we prepared an analysis of the fair values of the assets acquired and liabilities assumed as of the date of acquisition . the following table summarizes our allocation of the assets acquired and liabilities assumed as of the april 30 , 2014 acquisition date . story_separator_special_tag brands that can be continually enhanced by new product offerings generally warrant a higher valuation and longer life than a brand that has always “ followed the leader ” . after consideration of the factors described above , as well as current economic conditions and changing consumer behavior , management prepares a determination of an intangible asset 's value and useful life based on its analysis . under accounting guidelines , goodwill is not amortized , but must be tested for impairment annually , or more frequently if an event occurs or circumstances change that would more likely than not reduce the fair value of the reporting unit below the carrying amount . in a similar manner , indefinite-lived assets are not amortized . they are also subject to an annual impairment test , or more frequently if events or changes in circumstances indicate that the asset may be impaired . additionally , at each reporting period an evaluation must be made to determine whether events and circumstances continue to support an indefinite useful life . intangible assets with finite lives are amortized over their respective estimated useful lives and must also be tested for impairment whenever events or changes in circumstances indicate that the carrying value of the asset may not be recoverable and exceeds its fair value . on an annual basis , during the fourth fiscal quarter , or more frequently if conditions indicate that the carrying value of the asset may not be recovered , management performs a review of both the values and , if applicable , useful lives assigned to goodwill and intangible assets and tests for impairment . we report goodwill and indefinite-lived intangible assets in three reportable segments : north american otc healthcare , international otc healthcare and household cleaning . we identify our reporting units in accordance with the fasb asc subtopic 280. the carrying value and fair value for intangible assets and goodwill for a reporting unit are calculated based on key assumptions and valuation methodologies previously discussed . as a result , any material changes to these assumptions could require us to record additional impairment in the future . in the past , we have experienced declines in revenues and profitability of certain brands in the north american otc healthcare and household cleaning segments . sustained or significant future declines in revenue , profitability , other adverse changes in expected operating results , and or unfavorable changes in other economic factors used to estimate fair values of certain brands could indicate that fair value no longer exceeds carrying value , in which case a non-cash impairment charge may be recorded in future periods . 45 goodwill as of february 29 , our annual impairment review date , and march 31 , 2016 , we had 15 reporting units with goodwill . as part of our annual test for impairment of goodwill , management estimates the discounted cash flows of each reporting unit to estimate their respective fair values . in performing this analysis , management considers current information and future events , such as competition , technological advances and reductions in advertising support for our trademarks and trade names , that could cause subsequent evaluations to utilize different assumptions . in the event that the carrying amount of the reporting unit exceeds the fair value , management would then be required to allocate the estimated fair value of the assets and liabilities of the reporting unit as if the unit was acquired in a business combination , thereby revaluing the carrying amount of goodwill . indefinite-lived intangible assets at each reporting period , management analyzes current events and circumstances to determine whether the indefinite life classification for a trademark or trade name continues to be valid . if circumstances warrant a change to a finite life , the carrying value of the intangible asset would then be amortized prospectively over the estimated remaining useful life . management tests the indefinite-lived intangible assets for impairment by comparing the carrying value of the intangible asset to its estimated fair value . since quoted market prices are seldom available for trademarks and trade names such as ours , we utilize present value techniques to estimate fair value . accordingly , management 's projections are utilized to assimilate all of the facts , circumstances and expectations related to the trademark or trade name and estimate the cash flows over its useful life . in a manner similar to goodwill , future events , such as competition , technological advances and reductions in advertising support for our trademarks and trade names , could cause subsequent evaluations to utilize different assumptions . once that analysis is completed , a discount rate is applied to the cash flows to estimate fair value . in connection with this analysis , management : reviews period-to-period sales and profitability by brand ; analyzes industry trends and projects brand growth rates ; prepares annual sales forecasts ; evaluates advertising effectiveness ; analyzes gross margins ; reviews contractual benefits or limitations ; monitors competitors ' advertising spend and product innovation ; prepares projections to measure brand viability over the estimated useful life of the intangible asset ; and considers the regulatory environment , as well as industry litigation . finite-lived intangible assets when events or changes in circumstances indicate the carrying value of the assets may not be recoverable , management performs a review similar to indefinite-lived intangible assets to ascertain the impact of events and circumstances on the estimated useful lives and carrying values of our trademarks and trade names . if the analysis warrants a change in the estimated useful life of the intangible asset , management will reduce the estimated useful life and amortize the carrying value prospectively over the shorter remaining useful life . management 's projections are utilized to assimilate all of the facts , circumstances and expectations related to the trademark or trade name and estimate the cash flows over its useful life . future

